Skip to main content

Table 1 Human studies investigating the role of microbiomes in pancreatic cancer

From: Role of the microbiome in occurrence, development and treatment of pancreatic cancer

Study design

Patients or Samples

Content

Conclusion

Refs

Case-control study

·HOMIM: 10 PC & 10 controls

·16 of 410 bacterial taxa

Significant changes observed in the microbial composition between pancreatic cancer patients and healthy controls.

[11]

·qPCR: 28 PC & 27 chronic pancreatitis patients & 28 controls

·Neisseria elongata and Streptococcus mitis

Meta-analysis

8 studies of periodontitis or edentulism

RR for periodontitis and PC was 1.74 (95% CI 1.41–2.15] and 1.54 (95% CI 1.16–2.05) for edentulism

Both periodontitis and edentulism appear to be associated with PC, even after adjusting for common risk factors.

[16]

Prospective cohort study

Blood samples from 405 PC & 416 controls

Antibodies against Porphyromonas gingivalis ATCC 53978

Individuals with high levels of antibodies against Porphyromonas gingivalis ATCC 53978 had higher risk of PC.

[17]

Case-control study

16S rRNA of 30 PHC patients and 25 healthy controls

Microbiome diversity of the tongue coat

The microbiota dysbiosis of the tongue coat in PHC patients was identified.

[18]

Cohort study

Cyst fluid and plasma of suspected PCN

Bacterial 16S DNA copy number and IL-1β

Intracystic bacterial 16S DNA copy number and IL-1β protein quantity were significantly higher in IPMN.

[19]

Case-control study

Blood samples from 92 PC & 30 gastric cancer & 35 colorectal cancer & 27 controls

IgG antibodies against Hp

Suggested an association between Hp infection and pancreatic cancer.

[20]

Case-control study

·16S rRNA gene of 14 PC & 14 controls

Hp, IL-6 and CRP

PC patients had higher IL-6 and CRP in blood and a higher incidence of Hp in duodenum

[21]

·Blood samples

·Urea breath test

Meta-analysis

Blood samples of 580 PC & 626 controls

Hp and CagA

The evidence of CagA strain-specific associations is respective.

[22]

Meta-analysis

117 meta-analytical or pooled reports of the association between specific risk factors and PC risk.

Hp has estimated population attributable fractions is 4–25%.

Hp infection is the major risk factors associated with PC.

[23]

Meta-analysis

1003 PC & 1754 controls in 8 case-control studies

OR = 1.45 (95% CI: 1.09–1.92) between Hp and PC under the random effects model.

Hp infection can significantly increase the risk of developing pancreatic cancer.

[24]

Meta-analysis

2335 patients in 6 studies

AOR = 1.38 (95%CI: 1.08–1.75; P = 0.009) between Hp and PC

A significant association between Hp seropositivity and development of pancreatic cancer was seen

[25]

Meta-analysis

1083 PC & 1950 controls in 9 studies

OR = 1.47 (95%CI: 1.22–1.77) between Hp and PC

H. pylori infection is significantly, albeit weakly, associated with pancreatic cancer development.

[26]

Nested case-control study

104 cases randomly selected subjects among 507 developed PC, 262 cases from 730 controls

Hp and its CagA protein

Helicobacter pylori infection is not associated with development of PC.

[27]

Prospective cohort study

87 PC & 263 controls from residents born from 1921 to 1949 in Malmö, Sweden

Hp

No association between Hp infection and the risk for PC was found.

[28]

Meta-analysis

65,155 observations in 3 cohort studies and 6 nested case-control studies

OR  =  1.09(95%CI: 0.81–1.47)

The linkage of PC to Hp infection was not warranted on the whole.

[29]

Prospective cohort study

19,924 participants including 126 PC

Candida

Individuals with Candida-related lesions had a 70 80% excess risk of developing PC.

[30]

Population-based cohort study

34,829 patients from the National Health Insurance system of Taiwan

Candida

The risks of pancreatic cancer was significantly higher in the Candida Infection group.

[31]

  1. AOR, adjusted odds ratio; CagA, cytotoxin-associated gene-A; CI, confidence interval; CRP, C-reactive protein; HOMIM, Human Oral Microbiological Identification Microarrays; Hp, Helicobacter pylori; IgG, Immunoglobulin G; IL, interleukin; IPMN, intraductal papillary mucinous neoplasm; PC, pancreatic cancer; PCN, pancreatic cystic neoplasm; PHC, pancreatic head carcinoma; Porphyromonas gingivalis ATTC 53978, a pathogenic periodontal bacteria; qPCR, Real-time quantitative polymerase chain reaction; RR, relative risk